The Mission of the Ontario Rheumatology Association is to represent Ontario Rheumatologists and promote their pursuit of excellence in Arthritis care in Ontario through Leadership, Advocacy, Education and Communications.
  • ORA 14th Annual Meeting

    The ORA 2015 Annual Meeting is being held May 22-24, 2015. 

Recent News

  • EMR Funding Application Deadline

    New EMR Adoption Program Extension 2 - Funding
    The program has received funding for another year starting on April 1, 2014 and ending on March 31, 2015 (i.e., the program extension). The program will fund an additional 760 physicians and will focus on family physicians and community specialists who have not participated to date.
    Physicians considering an EMR should visit the New EMR Adoption Program Extension page for information on the Terms and Conditions of funding, eligibility criteria, requirements and to download an application form starting April 1, 2014. Your application must be received by OntarioMD by September 30, 2014, the application deadline.
    If you have applied to the program prior to September 30, 2013 deadline, but have not signed a Funding Agreement by March 31, 2014, you will need to submit a new application. Please visit the New EMR Adoption Program Extension page.

    https://www.ontariomd.ca/portal/server.pt/community/emr_funding/

  • Summer Newsletter

    Click here for the Summer 2014 ORA Newsletter. The newsletter includes an update from the new ORA President, Dr. Arthur Karasik. It also includes information regarding the EMR application deadline.

  • ORA/OPA Collaboration

    The ORA Models of Care Committee and the Ontario Pharmacists Association have partnered together to strengthen inter-professional communication and collaboration to enhance and optimize the quality of care for their patients.

    ORA/OPA Communication piece may be found here.

  • View All News

Upcoming Events for 2014

Corporate Sponsors

Diamond: The Arthritis Society, Pfizer Canada Inc., Amgen Canada Inc., Janssen Inc., Celgene Inc., Bristol-Myers Squibb Canada, Roche Canada
Platinum: GlaxoSmithKline Inc., UCB Canada Inc., AstraZeneca Canada Inc., Abbvie., Takeda Canada Inc.